Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD

Chest

Volumn 121, Issue 4, 2002, Pages 1058-1069

  Rossi, Andrea ^a   Kristufek, Peter ^b   Levine, Bernard E ^c   Thomson, Moira H ^d   Till, Denise ^d   Kottakis, John ^d   Della Cioppa, Giovanni ^d   Aigner, K ^c   Domej, W ^c   Puganigg, K ^c   Sertl, K ^c   Deman, R ^c   Vondra, V ^c   Erban, J ^c   Ostadal, O ^c   Merta, Z ^c   Skrickova, J ^c   Racineaux, J L ^c   Rochemaure, J ^c   Wallaert, C ^c   Aubier, M ^c   Muir, J F ^c   Lebas, X ^c   Zuck, P ^c   Vergnon, J M ^c   Matthys, H ^c   Scmidtmann, S ^c   Wagner, D H Worth ^c   Forster, A ^c   Constantopoulos, S ^c   Sichletidis, L ^c   Georgatou Papageorgiou, N ^c   Bahlitzanakis, N ^c   Bouros, D ^c   Magyar, P ^c   Gyorgy, B ^c   Fonay, Nagy K ^c   Berta, G ^c   Olivieri, D ^c   Paggiaro, P L ^c   Sanguinetti, C ^c   Potena, A ^c   Gandola, L ^c   Damato, G ^c   Franco, C ^c   Ambrosino, N ^c   Neri, M ^c   Cerveri, I ^c   Rossi, A ^c   Dottorini, M ^c   Pozzi, E ^c   Balduin, R ^c   Brusasco, V ^c   Magula, D ^c   Zucha, J ^c   Smith, C ^c   Foden, A P ^c   Brunig, A ^c   Linden, M Van Der ^c   Rossouw, I ^c   Laher, M ^c   Gispert, F J ^c   Martinez, J ^c   Morera, J ^c   De Lucas, P ^c   Izquierdo, J L ^c   Boada, J E ^c   Amgott, T R ^c   Benkert, R ^c   Bernstein, J A ^c   Bleeker, E ^c   Campbell, S C ^c   Collins, D ^c   DeGraff, A C ^c   Federman, E C ^c   Friedman, M ^c   Kreitzer, S ^c   Lisberg, E ^c   Lumry, W ^c   Miller, S D ^c   Murray, J J ^c   Ovetsky, R M ^c   Schelbar, E J ^c   Simon, S J ^c   Smith, H ^c   Wolfe, R ^c   more..

^a Bergamo General Hospital   (Italy)

^b Nemocnica Sv Kriza   (Slovakia)

^c Novartis Horsham Research Center ^*  (United States)

^d Novartis Horsham Research Center   (United Kingdom)

Author keywords

COPD; Formoterol; Inhaled lung function; Theophylline; 2 agonists

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FORMOTEROL; FORMOTEROL FUMARATE; PLACEBO; SALBUTAMOL; THEOPHYLLINE;

ABDOMINAL PAIN; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY POWDER; DYSPEPSIA; DYSPNEA; FEMALE; HEADACHE; HUMAN; INSOMNIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLOW RELEASE FORMULATION; SYMPTOM; TREATMENT OUTCOME; TREMOR; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VOMITING;

EID: 0036206172     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.4.1058     Document Type: Article

References (22)

1. ATS statement: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
2. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
3. BTS guidelines for the management of chronic obstructive pulmonary disease
4. 2-agonists in asthma therapy
5. 2-agonists in the management of stable chronic obstructive pulmonary disease
6. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium: A 3-week, randomized, double-blind, within-patient, multicenter study
7. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary
8. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
9. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease
10. Similar efficacy following four weeks treatment of asthmatics with formoterol 12 μg b.d. Delivered by two different dry powder inhalers: Differences in inhaler handling
11. Asthma
12. Bronchodilators, other agents used in asthma
13. The St. George's Respiratory Questionnaire
14. A self-complete measure of health status for chronic airflow limitation: The St. George's Respiratory Questionnaire
15. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease
16. Pharmacological therapy of obstructive airway disease
17. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung
18. Effect of beta-agonists on inflammatory cells
19. The anti-inflammatory profile of inhaled corticosteroids combined with salmeterol in asthmatic patients
20. Additive effects of salmeterol and fluticasone or theophylline in COPD
21. Slow-release theophylline: Rationale and basis for product selection
22. Update on the pharmacodynamics and pharmacokinetics of theophylline